Search

The article announces the submission by the U.S. Food and Drug Administration (FDA) of approval request to the U.S. Office of Management and Budget (OMB) for reporting requirements contained in "Environmental Impact Considerations."

The article focuses on a notice issued by the U.S. Food and Drug Administration (FDA). The notice informs that the FDA is submitting a collection of information to the U.S. Office of Management and Budget (OMB) titled as "Public Health Service Guideline on Infectious Disease Issues in Xenotransplantation". The notice invites comments on the proposed information collection which are to be sent to the OMB.

The article focuses on a notice issued by the U.S. Food and Drug Administration (FDA). The notice informs that the FDA is submitting a collection of information to the U.S. Office of Management and Budget (OMB) titled as "Survey on the Occurrence of Foodborne Illness Risk Factors in Selected Retail and Foodservice Facility Types". The notice invites comments on the proposed information collection which are to be sent to the OMB. A table containing the summary of data collection is presented.

The article focuses on a notice issued by the U.S. Food and Drug Administration (FDA) regarding solicitation of comments on the proposed information collection submitted for review to the U.S. Office of Management and Budget (OMB). Information collection entitled "Healthcare Professional Survey of Prescription Drug Promotion" will be weighted to physicians and nurse practitioners to adjust for unequal selection probabilities and deviations between the sample and population distributions.

The article focuses on a notice issued by the U.S. Food and Drug Administration (FDA) regarding solicitation of comments on the extension of proposed information collection submitted to the U.S. Office of Management and Budget (OMB). Information collection entitled "Environmental Impact Considerations" assesses the environmental impact of agency actions. The notice also contains several tables showing estimated annual reporting burden for human drugs, biological products and animal drugs.

The article focuses on the proposed collection of information submitted by the U.S. Food and Drug Administration (FDA) to the Office of Management and Budget (OMB) for review and clearance under Paperwork Reduction Act of 1995. The collection pertains to the reporting of harmful and potentially harmful substances in tobacco products and tobacco smoke under the Federal Food, Drug and Cosmetic Act. Comments on this information collection are accepted until August 29, 2012.

The article reports that the U.S. Department of Health and Human Services (HHS) is seeking clearance from the U.S. Office of Management and Budget regarding the public comments on the proposed information collection in accordance with the U.S. Paperwork Reduction Act of 1995. The HHS is soliciting public comments by July 20, 2012 via electronic mail or in writing.

The article reports that the U.S. Department of Health and Human Services (HHS) is seeking clearance from the U.S. Office of Management and Budget regarding the public comments on the proposed information collection in accordance with the U.S. Paperwork Reduction Act of 1995. The HHS is soliciting public comments by July 20, 2012 via electronic mail or in writing.

The article reports that the U.S. Food and Drug Administration is seeking clearance from the U.S. Office of Management and Budget regarding the public comments on the proposed information collection in accordance with the U.S. Paperwork Reduction Act of 1995. The notice is issued to check the performance of the agency, enhance quality, utility and clarity of information and minimize the burden of information collection on respondents and the use of automated collection techniques.

The article reports that the U.S. Food and Drug Administration is seeking clearance from the U.S. Office of Management and Budget regarding the public comments on proposed information collection in accordance with the Paperwork Reduction Act of 1995. It states that the notice is issued to check the performance of the agency, enhance quality, utility and clarity of information, and minimize burden of information collection on respondents and the use of automated collection techniques.

The article reports that the U.S. Food and Drug Administration is seeking clearance from the U.S. Office of Management and Budget regarding the public comments on the proposed information collection on the food contact substance notification program related to food packaging and manufacturing in accordance with the U.S. Paperwork Reduction Act of 1995. The agency is soliciting public comments by July 12, 2012 via fax.

The article reports that the U.S. Food and Drug Administration is seeking clearance from the U.S. Office of Management and Budget regarding the public comments on proposed information collection its provision related to biosimilar applications in accordance with the Paperwork Reduction Act of 1995. The agency is soliciting public comments by June 25, 2012 via electronic mail or in writings.

The article focuses on a notice submitted by the U.S. Food and Drug Administration of the U.S. Department of Health and Human Services to the U.S. Office of Management and Budget to make an information collection request (ICR) regarding the labeling and effectiveness testing requirements for certain over-the-counter sunscreen drug products. The ICR will be made in accordance with the U.S. Paperwork Reduction Act of 1995. The public comments have been invited till June 8, 2012.

The article offers information on a notice issued by the U.S. Food and Drug Administration requesting comments on a proposed information collection request (ICR) related to the regulations of public display and labeling of food products of harmful health-related condition and tobacco constituents. The ICR will be submitted to the U.S. Office of Management and Budget for approval in accordance with the U.S Federal Food, Drug, and Cosmetic Act. The comments have been invited till June 7, 2012.

The article presents information on a notice submitted by the U.S. Food and Drug Administration to the U.S. Office of Management and Budget to make an information collection request (ICR) to conduct survey for serious adverse drug reactions and inspection of drug manufacturing facilities as per the U.S. Federal Food, Drug, and Cosmetic Act. The ICR will be made in accordance with the U.S. Paperwork Reduction Act of 1995. The public comments have been invited till April 25, 2012.

The article reports that the U.S. Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services has submitted a notice to the U.S. Office of Management and Budget to make an information collection request (ICR) to evaluate consumer behavior regarding the labels on food packages. As per the notice, the ICR has been made under the U.S. Paperwork Reduction Act of 1995. It also mentions that the public comments have been invited till March 28,2012.

The article presents a notice from the U.S. Department of Health and Services (HHS) and the Food and Drug Administration (FDA). It mentions that the notice includes the proposed collection of information to be submitted for review by the Office of Management and Budget (OMB) and industrial guidance on petitions to the Federal Food, Drug and Cosmetic Act. It also suggests to fax written comments about the notice to the Office of Information and Regulatory Affairs.

A notice from the U.S. Food and Drug Administration (FDA) announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995 is presented.

The article focuses on a notice issued by the U.S. Food and Drug Administration (FDA) regarding solicitation of comments on the proposed information collection submitted to the U.S. Office of Management and Budget (OMB). Information collection entitled "Regulations Restricting the Sale and Distribution of Cigarettes and Smokeless Tobacco to Protect Children and Adolescents" requires manufacturers to observe requirements for advertising and directs to use black text on a white background.

The article focuses on a notice issued by the U.S. Food and Drug Administration (FDA) regarding solicitation of comments on the information collection submitted to the U.S. Office of Management and Budget (OMB). Information collection entitled "Experimental Study of Consumer Response to Health Claims and Disclaimers about the Relationship between Selenium and Risk of Various Cancers" examines consumer interpretations of dietary supplement claims and their reactions to health claims.

The article reports a notice issued by the U.S. Food and Drug Administration (FDA) seeking comments regarding proposed information collection related to dietary supplement labeling requirements and recommendations, under the provisions of the U.S. Paperwork Reduction Act of 1995. It mentions that the same shall be submitted to the U.S. Office of Management and Budget (OMB) for review and clearance. It also states that the comments regarding the same must reach FDA by September 21, 2012.

The article presents the notice of the Food and Drug Administration (FDA) that seeks written comments for the proposed information collection application filed at the Office of Management and Budget (OMB) for the listing and registration of tobacco owners and operators in the U.S. It mentions the details on when and where the collected comments are received. Moreover, the extension of registration and listing of operators and owners of tobacco products are also mentioned.

The article presents a notice from the U.S. Food and Drug Administration (FDA) of the Department of Health and Human Services on the availability of the draft guidance entitled "Acceptance and Filing Review for Premarket Approval Applications (PMAs)." The guidance aims of making a threshold determination about whether an application is administratively complete and clarifying the criteria for accepting and filing a PMA. The guidance is under review by the Office of Management and Budget (OMB).

The article presents a notice from the U.S. Food and Drug Administration (FDA) regarding its information collection project. It mentions that the FDA has submitted their proposed collection of information regarding the labeling of beers to the Office of Management and Budget (OMB) for review and clearance. It notes that the agency will accept public comments on the action until August 23, 2012.

The article offers information on the notice issued by the U.S. Food and Drug Administration (FDA) that announces the review of the proposed collection of information. It mentions the recommendations from the Office of Management and Budget (OMB) to fax comments to ensure that it will be received by the agency. A chart that depicts the estimates of burden in information collection is also presented.

The article presents information that the U.S. Food and Drug Administration (FDA) is seeking clearance from the U.S. Office of Management and Budget regarding the public comments on the proposed information collection on the postmarketing adverse drug experience in accordance with the U.S. Paperwork Reduction Act of 1995. The FDA is soliciting public comments by July 27, 2012 via electronic mail or in writing.

The article presents information that the U.S. Food and Drug Administration (FDA) is seeking clearance from the U.S. Office of Management and Budget regarding the public comments on the proposed information collection on a pilot study of medical devices in accordance with the U.S. Paperwork Reduction Act of 1995. The FDA is soliciting public comments by July 27, 2012 via electronic mail or in writing.

The article reports that the U.S. Administration for Children and Families (ACF) is seeking clearance from the U.S. Office of Management and Budget for the public comments on the information collection in accordance with the U.S. Paperwork Reduction Act of 1995. The ACF wants to collect data for the biosimilar or interchangeable biological products. The ACF is soliciting public comments by July 18, 2012 via electronic mail or through fax.

The article reports that the U.S. Food and Drug Administration is seeking clearance from the U.S. Office of Management and Budget regarding the public comments on the proposed information collection in accordance with the U.S. Paperwork Reduction Act of 1995. The notice is issued to check the performance of the agency, enhance quality, utility and clarity of information and minimize the burden of information collection on respondents and the use of automated collection techniques.

The article reports that the U.S. Food and Drug Administration is seeking clearance from the U.S. Office of Management and Budget regarding public comments on proposed information collection in accordance with the Paperwork Reduction Act of 1995. It states that the notice has been issued to collect data on reporting by the medical device manufacturers.

The article reports that the U.S. National Institutes of Health is seeking clearance from the U.S. Office of Management and Budget regarding public comments on proposed information collection in accordance with the Paperwork Reduction Act of 1995. It states that the notice is issued to check the performance of the agency, enhance quality, utility and clarity of information, and minimize burden of information collection on respondents and the use of automated collection techniques.

The article reports that the U.S. Food and Drug Administration is seeking clearance from the U.S. Office of Management and Budget regarding public comments on proposed information collection in accordance with the Paperwork Reduction Act of 1995. It states that the notice is issued to check the performance of the agency, enhance quality, utility and clarity of information, and minimize burden of information collection on respondents and the use of automated collection techniques.

The article reports that the U.S. Food and Drug Administration is seeking clearance from the U.S. Office of Management and Budget regarding the public comments on proposed information collection on the marketing of nonprescription human drug products without an approved application in accordance with the Paperwork Reduction Act of 1995. The agency is soliciting public comments by June 25, 2012 via electronic mail or in writings.

The article reports that the U.S. Food and Drug Administration is seeking clearance from the U.S. Office of Management and Budget for the public comments on proposed information collection in accordance with the Paperwork Reduction Act of 1995. It states that the notice is issued to check the performance of the agency, enhance quality, utility and clarity of information, and minimize burden of information collection on respondents and the use of automated collection techniques.

The article offers information on a notice issued by the U.S. Food and Drug Administration regarding the submission of information collection request for the project titled "Experimental Study on Comparing Data Obtained From Landline Telephone and Cell Phone Surveys" to the U.S. Office of Management and Budget for review and approval under the U.S. Paperwork Reduction Act of 1995 Written comments on the same must be received by June 18, 2012.

The article reports that the U.S. Food and Drug Administration is seeking clearance from the U.S. Office of Management and Budget regarding public comments on proposed information collection in accordance with the Paperwork Reduction Act of 1995. It states that the notice is issued to check the performance of the agency, enhance quality, utility and clarity of information, and minimize burden of information collection on respondents and the use of automated collection techniques.

The article offers information on a notice issued by the U.S. Food and Drug Administration requesting comments on a proposed information collection request (ICR) related to the regulations of reporting and registration of domestic tobacco product listing for owners and operators. The ICR will be submitted to the U.S. Office of Management and Budget for approval in accordance with the U.S Tobacco Control Act. The public comments have been invited till July 2, 2012.

The article reports on a notice issued by the U.S. Food and Drug Administration (FDA) inviting public comments on the proposed information collection in accordance with the U.S. Paperwork Reduction Act of 1995. The FDA has also submitted to the U.S. Office of Management and Budget (OMB) for review and clearance of the collected information. The FDA is seeking comments from public related to it on or before May 21, 2012.

The article presents information on a notice submitted by the U.S. Food and Drug Administration of the U.S. Department of Health and Human Services to the U.S. Office of Management and Budget to make an information collection request (ICR) with an intention to provide guidance for industry on formal dispute resolution. The ICR will be made under the U.S. Paperwork Reduction Act of 1995. The public comments have been invited by the EPA till May 21, 2012 regarding the ICR.

The article reports on a notice submitted by the U.S. Food and Drug Administration of the U.S. Department of Health and Human Services to the U.S. Office of Management and Budget to make an information collection request (ICR) with an intention to provide industry guidance on formal meetings with the dealers of prescription drugs. The ICR will be made under the U.S. Paperwork Reduction Act of 1995. The public comments have been invited by the EPA till May 21, 2012 regarding the ICR.

The article reports on a notice submitted by the U.S. Food and Drug Administration of the U.S. Department of Health and Human Services to the U.S. Office of Management and Budget to make an information collection request (ICR) regarding the requirements of reporting and recordkeeping of the postmarketing of adverse drug experience. The ICR will be made under the U.S. Paperwork Reduction Act of 1995. The public comments have been invited by the EPA till May 21, 2012 regarding the ICR.

The article reports that the Food and Drug Administration (FDA) has announced that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995. This collection of information gathers data for FDA-regulated products being imported into the U.S. It also discusses Section 801 of the Federal Food, Drug, and Cosmetic Act.

The article offers information on a notice published by the U.S. Food and Drug Administration (FDA) requesting the public to comment on its application for its proposed collection of information submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995. Information is provided on the deadline for the submission of comments and the addresses where comments may be forwarded.

This article presents a notice of a proposed collection of information submitted to the U.S. Office of Management and Budget for review and clearance under the Paperwork Reduction Act of 1995, issued by the U.S. Food and Drug Administration.

The article offers information about a notice issued by the U.S. Food and Drug Administration seeking comments regarding a proposed information collection request (ICR) related to the use of constituent materials in biological products. It mentions that the same shall be submitted to the U.S. Office of Management and Budget for review and clearance under the U.S. Paperwork Reduction Act. It further states that the comments regarding the ICR must be received on or before January 28, 2013.

The article informs about a notice issued by the U.S. Food and Drug Administration (FDA) informing about the approval of information collection by the U.S. Office of Management and Budget (OMB) concerning registration and product listing for owners and operators of domestic tobacco product.

The article focuses on a notice issued by the U.S. Food and Drug Administration (FDA) regarding solicitation of comments on an information collection (IC) submitted to the U.S. Office of Management and Budget (OMB). IC entitled "Draft Guidance for Industry on Safety Labeling Changes: Implementation of Section 505(o) (4) of the Federal Food, Drug and Cosmetic Act" authorizes FDA to make changes based on new safety information required by drug and biological product application holders.

The article offers information about a notice issued by the U.S. Food and Drug Administration (FDA). The notice informs that the FDA invites public comments on the information collection request for extending the information collection including the food additive petitions regarding animal food by the U.S. Office of Management and Budget (OMB). The written comments on the proposed information collection request are sent to the FDA in Maryland.

The article offers information about a notice issued by the U.S. Food and Drug Administration (FDA). The notice informs about the submission of information collection entitled "Prescription Drug User Fee Cover Sheet Form FDA 3397" to the U.S. Office of Management and Budget (OMB) for its review. The notice invites public comments on the proposed information collection.

The article offers information on a notice issued by the U.S. Department of Health and Human Services regarding the submission of proposed collection of information by the U.S. Food and Drug Administration (FDA) for the U.S. Office of Management and Budget (OMB) review. It mentions that public opinion will be accepted until October 25, 2012. It further informs that the guidance helps in developing risk-based monitoring strategies for the study of medical products.